Product Program year 2025 Source: CMS Open Payments

Natrelle Saline-Filled Breast Implants

Device Plastic Surgery

PDI 10888628000155

Open in the dashboard

General payments

$9,170,526

46,488 payments

Research payments

$183,206

73 payments

Through program year 2025, $9,170,526 in general payments and $183,206 in research payments were reported against Natrelle Saline-Filled Breast Implants (Plastic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $2,415,417 12,398
2025 Research $14,086 12
2024 General $4,302,001 18,846
2024 Research $73,568 22
2023 General $2,453,096 15,243
2023 Research $95,552 39
2022 General $12 1

Breakdown

Who paid General payments · program years 2022–2025
  1. AbbVie, Inc. $9,170,526 46,488 payments
Top recipients General payments · program year 2025
  1. Nicholas Clavin Plastic Surgery · Charlotte, NC $135,222 6% · 100 payments
  2. Allen Gabriel Plastic Surgery · Vancouver, WA $118,961 5% · 69 payments
  3. John Apostolides Plastic Surgery · San Diego, CA $111,701 5% · 70 payments
  4. Michael Edwards Plastic Surgery · Las Vegas, NV $99,263 4% · 70 payments
  5. Maurice Nahabedian Plastic and Reconstructive Surgery · Mc Lean, VA $94,883 4% · 54 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $1,470,055 69% · 1,322 practitioners
  2. Plastic and Reconstructive Surgery Surgery $438,735 21% · 736 practitioners
  3. Surgery $52,578 2% · 221 practitioners
  4. Dermatology $45,535 2% · 62 practitioners
  5. Optometrist $22,466 1% · 2 practitioners

The top 5 of 96 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $351,191 15% · 546 recipients
  2. North Carolina $298,717 12% · 108 recipients
  3. Texas $290,956 12% · 367 recipients
  4. Florida $222,431 9% · 483 recipients
  5. Washington $129,828 5% · 71 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

46,488 general · 73 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record